LPCN logo

Lipocine (LPCN) Cash From Investing

Annual CFI

$13.08 M
-$1.21 M-8.46%

December 31, 2023

Summary

Performance

1-Year Change

-8.46%

3-Year Change

+236.13%

5-Year Change

+15.86%

15-Year Change

+318.58%

LPCN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.65%
LPCN annual cash flow from investing activities is higher than 78.65% of companies in Healthcare sector

High & Low

All-time High

$14.29 M
LPCN annual cash flow from investing activities is currently -8.46% below its historical high of $14.29 million

3-Year Low

-$43.78 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LPCN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
LPCN next annual earnings announcement is scheduled for Mar 7, 2025

OtherLPCNcash flowmetrics:

Annual CFF

$404.60 K
LPCN annual cash flow from financing activities is $404.60 thousand

Annual CFO

-$11.87 M
LPCN annual cash flow from operations is -$11.87 million

Annual FCF

-$11.88 M
LPCN annual free cash flow is -$11.88 million

Annual CAPEX

$13.20 K
LPCN annual capital expenditures is $13.20 thousand

Quarterly CFI

$1.02 M
-$3.73 M-78.48%

September 30, 2024

Summary

Performance

3-Month Change

-78.48%

1-Year Change

-62.5%

3-Year Change

-71.28%

5-Year Change

-71.28%

LPCN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.84%
LPCN quarterly cash flow from investing activities is higher than 74.84% of companies in Healthcare sector

High & Low

All-time High

$8.69 M
LPCN quarterly cash flow from investing activities is currently -88.23% below its historical high of $8.69 million

3-Year Low

-$9.72 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LPCN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
LPCN next earnings announcement is scheduled for Mar 7, 2025

OtherLPCNcash flowmetrics:

Quarterly CFF

$0.00
LPCN quarterly cash flow from financing activities is $0.00

Quarterly CFO

-$2.83 M
LPCN quarterly cash flow from operations is -$2.83 million

Quarterly FCF

-$2.91 M
LPCN quarterly free cash flow is -$2.91 million

Quarterly CAPEX

-
LPCN quarterly capital expenditures value is unknown

TTM CFI

$4.41 M
-$220.50 K-4.76%

September 30, 2024

Summary

Performance

3-Month Change

-4.76%

1-Year Change

-66.28%

3-Year Change

-64.21%

5-Year Change

-64.21%

LPCN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.2%
LPCN TTM cash flow from investing activities is higher than 76.2% of companies in Healthcare sector

High & Low

All-time High

$14.29 M
LPCN TTM cash flow from investing activities is currently -69.13% below its historical high of $14.29 million

3-Year Low

-$43.78 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LPCN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
LPCN next earnings announcement is scheduled for Mar 7, 2025

OtherLPCNcash flowmetrics:

TTM CFF

$204.00 K
LPCN TTM cash flow from financing activities is $204.00 thousand

TTM CFO

-$4.95 M
LPCN TTM cash flow from operations is -$4.95 million

TTM FCF

-$5.03 M
LPCN TTM free cash flow is -$5.03 million

TTM CAPEX

-
LPCN TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

LPCN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.5%-62.5%-66.3%
3 y3 years+236.1%-71.3%-64.2%
5 y5 years+15.9%-71.3%-64.2%

LPCN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.5%+129.9%-86.0%+110.5%-69.1%+110.1%
5 y5-year-8.5%+129.9%-86.0%+103.0%-69.1%+110.1%
alltimeall time-8.5%+129.9%-88.2%+103.0%-69.1%+110.1%

Lipocine Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.02 M(-78.5%)
$4.41 M(-4.8%)
Jun 2024
-
$4.75 M(-216.2%)
$4.63 M(+34.7%)
Mar 2024
-
-$4.09 M(-250.0%)
$3.44 M(-73.7%)
Dec 2023
$13.08 M(-8.5%)
$2.73 M(+119.4%)
$13.08 M(+1.0%)
Sep 2023
-
$1.24 M(-65.1%)
$12.95 M(+5.1%)
Jun 2023
-
$3.56 M(-35.9%)
$12.33 M(-1.8%)
Mar 2023
-
$5.55 M(+113.9%)
$12.55 M(-12.2%)
Dec 2022
$14.29 M(-132.6%)
$2.60 M(+322.9%)
$14.29 M(+623.8%)
Sep 2022
-
$613.90 K(-83.8%)
$1.97 M(-27.6%)
Jun 2022
-
$3.79 M(-48.1%)
$2.73 M(-209.6%)
Mar 2022
-
$7.30 M(-175.0%)
-$2.49 M(-94.3%)
Dec 2021
-$43.78 M(-1224.7%)
-$9.72 M(-810.5%)
-$43.78 M(+52.8%)
Sep 2021
-
$1.37 M(-195.6%)
-$28.65 M(-8.8%)
Jun 2021
-
-$1.43 M(-95.8%)
-$31.42 M(-7.6%)
Mar 2021
-
-$33.99 M(-728.6%)
-$34.00 M(-973.5%)
Dec 2020
$3.89 M(+29.8%)
$5.41 M(-486.7%)
$3.89 M(-506.4%)
Sep 2020
-
-$1.40 M(-65.2%)
-$957.90 K(-114.9%)
Jun 2020
-
-$4.02 M(-203.0%)
$6.41 M(-28.6%)
Mar 2020
-
$3.90 M(+600.1%)
$8.98 M(+199.6%)
Dec 2019
$3.00 M(-73.5%)
$557.40 K(-90.7%)
$3.00 M(-59.4%)
Sep 2019
-
$5.97 M(-512.4%)
$7.39 M(-6.3%)
Jun 2019
-
-$1.45 M(-30.5%)
$7.89 M(-22.0%)
Mar 2019
-
-$2.08 M(-142.1%)
$10.11 M(-10.4%)
Dec 2018
$11.29 M
$4.95 M(-23.6%)
$11.29 M(+148.9%)
Sep 2018
-
$6.47 M(+728.5%)
$4.54 M(-163.8%)
Jun 2018
-
$780.90 K(-186.5%)
-$7.11 M(-994.5%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$903.20 K(-50.1%)
$794.90 K(-74.6%)
Dec 2017
$3.13 M(-3.2%)
-$1.81 M(-65.1%)
$3.13 M(-59.7%)
Sep 2017
-
-$5.18 M(-159.6%)
$7.76 M(-16.7%)
Jun 2017
-
$8.69 M(+508.3%)
$9.33 M(+128.9%)
Mar 2017
-
$1.43 M(-49.5%)
$4.08 M(+26.2%)
Dec 2016
$3.23 M(-112.9%)
$2.83 M(-178.2%)
$3.23 M(-632.4%)
Sep 2016
-
-$3.62 M(-205.3%)
-$606.50 K(-89.7%)
Jun 2016
-
$3.43 M(+490.0%)
-$5.86 M(-76.0%)
Mar 2016
-
$582.10 K(-157.9%)
-$24.42 M(-2.4%)
Dec 2015
-$25.02 M(>+9900.0%)
-$1.01 M(-88.7%)
-$25.02 M(+4.0%)
Sep 2015
-
-$8.87 M(-41.4%)
-$24.05 M(+58.2%)
Jun 2015
-
-$15.13 M(>+9900.0%)
-$15.20 M(>+9900.0%)
Mar 2015
-
-$13.20 K(-65.5%)
-$49.70 K(+29.4%)
Dec 2014
-$38.40 K(+3100.0%)
-$38.30 K(+97.4%)
-$38.40 K(>+9900.0%)
Sep 2014
-
-$19.40 K(-191.5%)
-$100.00(-100.6%)
Jun 2014
-
$21.20 K(-1215.8%)
$18.10 K(-683.9%)
Mar 2014
-
-$1900.00(<-9900.0%)
-$3100.00(+158.3%)
Dec 2013
-$1200.00(<-9900.0%)
$0.00(-100.0%)
-$1200.00(-110.7%)
Sep 2013
-
-$1200.00(<-9900.0%)
$11.20 K(>+9900.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(-100.0%)
$0.00(0.0%)
Dec 2012
$0.00(0.0%)
$12.40 K(-200.0%)
$0.00(-100.0%)
Sep 2012
-
-$12.40 K(<-9900.0%)
-$12.40 K(<-9900.0%)
Jun 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00
$0.00
Dec 2011
$0.00
-
-

FAQ

  • What is Lipocine annual cash flow from investing activities?
  • What is the all time high annual CFI for Lipocine?
  • What is Lipocine annual CFI year-on-year change?
  • What is Lipocine quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Lipocine?
  • What is Lipocine quarterly CFI year-on-year change?
  • What is Lipocine TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Lipocine?
  • What is Lipocine TTM CFI year-on-year change?

What is Lipocine annual cash flow from investing activities?

The current annual CFI of LPCN is $13.08 M

What is the all time high annual CFI for Lipocine?

Lipocine all-time high annual cash flow from investing activities is $14.29 M

What is Lipocine annual CFI year-on-year change?

Over the past year, LPCN annual cash flow from investing activities has changed by -$1.21 M (-8.46%)

What is Lipocine quarterly cash flow from investing activities?

The current quarterly CFI of LPCN is $1.02 M

What is the all time high quarterly CFI for Lipocine?

Lipocine all-time high quarterly cash flow from investing activities is $8.69 M

What is Lipocine quarterly CFI year-on-year change?

Over the past year, LPCN quarterly cash flow from investing activities has changed by -$1.70 M (-62.50%)

What is Lipocine TTM cash flow from investing activities?

The current TTM CFI of LPCN is $4.41 M

What is the all time high TTM CFI for Lipocine?

Lipocine all-time high TTM cash flow from investing activities is $14.29 M

What is Lipocine TTM CFI year-on-year change?

Over the past year, LPCN TTM cash flow from investing activities has changed by -$8.67 M (-66.28%)